Objective: We report probably the first case of bilateral irreversible sensorineural hearing loss caused by Imatinib.
Method: A review of the world literature, concerning Imatinib toxicity is presented.
Results: We report a case of bilateral irreversible sensorineural hearing loss, in a 19-year-old male patient of chronic myeloid leukemia after 3 months of Imatinib therapy. Audiometric evaluation documented the findings.
Conclusion: To the best of our knowledge, this is the first case report of Imatinib induced sensorineural hearing loss. This case indicates that treating oncologists should keep in mind that this drug too can produce ototoxicity.